Loading provider…
Loading provider…
Allergy Physician in Lancaster, CA
NPI: 1255353629Primary Practice Location
Ricardo Antonio Tan MD Inc.
44453 16th W St, Lancaster, CA
Primary Employer
Ricardo Antonio Tan MD Inc.
calallergy.com
HQ Phone
Get MD Ricardo's Phone Numberphone_androidMobile
Get MD Ricardo's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
1993 - 2027
CT State Medical License
1991 - 1994
CA State Medical License

American Board of Allergy and Immunology
Allergy & Immunology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Allergy and Immunology
1993 - 1995
University at Buffalo (Mercy Hospital)
Residency • Internal Medicine
1988 - 1991
University of the Philippines College of Medicine
Medical School
Until 1986
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 122 | 422 |
| 2 | 94010Measurement and graphic recording of total and timed exhaled air capacity | 45 | 83 |
| 3 | 95004Injection of allergenic extracts into skin, accessed through the skin | 32 | 2,656 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 30 | 30 |
| 5 | 95117Injection of incremental dosages of allergen, 2 or more injections | 28 | 360 |
Advances in allergic skin disease: omalizumab is a promising therapy for urticaria and angioedema.
Authors: Spector, Sheldon L, Tan, Ricardo A
Journal: J Allergy Clin Immunol
Publication Date: 2008-09-05
Effect of omalizumab on patients with chronic urticaria
Authors: Maurer, Marcus, Casale, Thomas B, Saini, Sarbjit S, Ben-Shoshan, Moshe, Giménez-Arnau, Ana M, Bernstein, Jonathan A, Yagami, Akiko, Stjepanovic, Aleksandra, Radin, Allen, Staudinger, Heribert W, Patel, Naimish, Amin, Nikhil, Akinlade, Bolanle, Fan, Chunpeng, Bauer, Deborah, Yancopoulos, George D, Patel, Kiran, Mannent, Leda P, Laws, Elizabeth
Journal: J Allergy Clin Immunol
Publication Date: 2024-02-29
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: GSK3511294
Lead Sponsor: ALK-Abelló A/S
Intervention / Treatment: OTHER: Placebo, BIOLOGICAL: Sublingual allergy immunotherapy tablet
Lead Sponsor: Verona Pharma plc
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, DRUG: Ensifentrine